OR
ELV icon

Olympiad Research’s Elevance Health ELV Stock Holding History

Olympiad Research’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-951
Closed -$255K – 189
2020
Q3 		$255K Buy
+951
New +$256K 0.13% 210
2020
Q2 		– Sell
-1,434
Closed -$326K – 320
2020
Q1 		$326K Buy
1,434
+511
+55% +$139K 0.33% 85
2019
Q4 		$279K Buy
+923
New +$254K 0.21% 109

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Olympiad Research's ELV Position: Q4 2020 in Review

Olympiad Research sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 951 shares — an estimated $255K sold.

Olympiad Research first reported a position in ELV in Q4 2019 and held it in 3 quarters. The position peaked at $326K in Q1 2020. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Olympiad Research reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Olympiad Research sold 951 Elevance Health shares in Q4 2020, an estimated $255K.
  • Olympiad Research first reported a position in Elevance Health in Q4 2019 and held it in 3 quarters.
  • Olympiad Research's Elevance Health position peaked at $326K in Q1 2020.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Olympiad Research's 13F filing for Q4 2020, filed 5 Feb 2021.